(Q33400986)
Statements
1 reference
U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis (English)
1 reference
Albert Deisseroth
1 reference
Edvardas Kaminskas
1 reference
Joseph Grillo
1 reference
Wei Chen
1 reference
Haleh Saber
1 reference
Hong L Lu
1 reference
Mark D Rothmann
1 reference
Satjit Brar
1 reference
Jian Wang
1 reference
Julie Bullock
1 reference
Laurie B Burke
1 reference
Atiqur Rahman
1 reference
Rajeshwari Sridhara
1 reference
Ann Farrell
1 reference
Richard Pazdur
1 reference
1 reference
Identifiers
1 reference